Furthermore, TGF-β1 inhibition reduced 344SQ migration, a result that was consistent with a study that reported a combination of TGF-β1 and TGF-β2 neutralizing antibodies decreased endothelial cell-stimulated migration of lung carcinoma and normal mammary epithelial cells46. The gene discussed is TGFB1; the disease is lung carcinoma.